Antimicrobial Agents and Chemotherapy, June 2000, p. 1549-1555, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Bacteriology, Juntendo University, Tokyo, Japan
Received 10 December 1999/Returned for modification 30 January 2000/Accepted 10 March 2000
| |
ABSTRACT |
|---|
|
|
|---|
We have previously shown that the methicillin-resistance gene mecA of Staphylococcus aureus strain N315 is localized within a large (52-kb) DNA cassette (designated the staphylococcal cassette chromosome mec [SCCmec]) inserted in the chromosome. By sequence determination of the entire DNA, we identified two novel genes (designated cassette chromosome recombinase genes [ccrA and ccrB]) encoding polypeptides having a partial homology to recombinases of the invertase/resolvase family. The open reading frames were found to catalyze precise excision of the SCCmec from the methicillin-resistant S. aureus chromosome and site-specific as well as orientation-specific integration of the SCCmec into the S. aureus chromosome when introduced into the cells as a recombinant multicopy plasmid. We propose that SCCmec driven by a novel set of recombinases represents a new family of staphylococcal genomic elements.
| |
INTRODUCTION |
|---|
|
|
|---|
Methicillin-resistant
Staphylococcus aureus (MRSA) was first isolated in England
in 1961 shortly after the development of methicillin, the first
penicillinase-resistant semisynthetic penicillin (15). Since
then, MRSA has become the most prevalent pathogen causing hospital
infection throughout the world, and MRSA incidence is still increasing
in many countries (1). MRSA is resistant to practically all
-lactam antibiotics, a class of antibiotics represented by
penicillins and cephalosporins (3).
The
-lactam resistance of MRSA is caused by the production of a
novel penicillin-binding protein (PBP) designated PBP 2' (or PBP 2a),
which, unlike the intrinsic set of PBPs (PBP 1 to 4) of S. aureus, has remarkably reduced binding affinities to
-lactam
antibiotics (9, 24, 30). Despite the presence of otherwise
inhibitory concentrations of
-lactam antibiotics, MRSA can
continue cell wall synthesis solely depending upon the uninhibited
activity of PBP 2' (21). PBP 2' is encoded by a mecA gene located on the chromosome of MRSA. In 1987, the
mecA gene was cloned from a Japanese MRSA strain, and
its sequence was determined (20, 26). The
mecA gene is widely distributed among S. aureus as well as coagulase-negative staphylococci (13, 28). Therefore, it has been speculated that the methicillin resistance determinant (mec determinant) is freely
transmissible among staphylococcal species. However, with a detailed
molecular epidemiological study, Kreiswirth et al. have proposed that
MRSA originated from a single or two ancestral clones (16).
This led to the view that the frequency of inter- or intraspecies
transmission of mecA is a rather limited process and that
mec transmission may not be due to specialized transmission
machinery, such as a transposon.
We have recently cloned and sequenced the entire chromosomal region surrounding the mecA gene, which is additionally present in the MRSA chromosome and is absent from the chromosome of methicillin-susceptible S. aureus (MSSA) (referred to herein as mecDNA), from a Japanese pre-MRSA strain, N315 (10). We identified the mecDNA-S. aureus chromosome junction points and the overall structure of mecDNA, and revealed that mecDNA constitutes a genomic island or antibiotic resistance island of S. aureus (14). In this study, based on the structure of mecDNA, we report that mecDNA is a new class of genomic element designated SCCmec (for staphylococcal cassette chromosome mec [12]) driven by two site-specific recombinase genes designated ccrA and ccrB (for cassette chromosome recombinases A and B).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacteria and growth condition. Pre-MRSA strain N315 and its SCCmec excising strain N315ex used in this study have been described previously (14). All the strains and their transformants were cultivated in brain heart infusion (BHI) broth (Becton Dickinson Microbiology Systems, Sparks, Md.). The antibiotics tetracycline (Sigma Chemical Co., St. Louis, Mo.) and tobramycin (Shionogi Co., Osaka, Japan) were used at the concentration of 10 µg/ml.
Construction of recombinant plasmids.
Recombinant plasmid
pSR harboring intact ccrA and ccrB genes was
constructed by cloning the BamHI-digested DNA fragment
containing ccr genes into the unique BamHI site
of the plasmid vector pYT3 (8). The DNA fragment containing
ccr genes was prepared by PCR using the DNA extracted from
N315 as a template. The two primers used were
5'-AAAAGGATCCATTAGCCGATTTGGTAATTGAA-3' and
5'-AAAAGGATCCTCTGCTTCTTCGAATCTGCAAAT-3' (introduced BamHI sites are underlined), which
correspond to the nucleotides from base positions 24,004 to 24,025, and
to the complementary nucleotides from positions 27,365 to 27,343 of the
SCCmec sequence (accession no. D86934),
respectively. To construct pSRA*, the BamHI fragment of pSR
was subcloned into the BamHI site of pUC119
H, a
derivative of pUC119 whose HindIII site had been
eliminated by treatment with the Klenow fragment of DNA polymerase I
and self-ligation. The resultant plasmid, pUCSR, was digested with BalI and HindIII and flush ended by Klenow
treatment, which was followed by ligation to delete the
BalI-HindIII fragment (344 bp) of the
ccrA gene. Then, the BamHI fragment was cut out
of the plasmid and was ligated into the BamHI site of pYT3
to obtain pSRA*. To construct pSRB*, pUCSR was cut with
BstXI and MluI to remove the 252-bp
BstXI-MluI fragment of the ccrB gene,
and this was followed by Klenow treatment and self-ligation. The
BamHI fragment of the resultant plasmid was cut out and
ligated into the BamHI site of pYT3 to obtain pSRB*.
Nucleotide sequencing. The DNA fragments for sequencing were obtained by PCR amplification with genomic DNA as templates. After purification using a QIAquick PCR purification kit (QIAGEN, Hilden, Germany), the fragments of PCR products were directly sequenced with a set of synthetic oligonucleotide primers (see below) using a dye-labeled terminator-Taq DNA polymerase cycle sequencing kit (Applied Biosystems Inc., Foster City, Calif.). The sequence was read on a 373A automated fluorescent DNA sequencing system (Perkin-Elmer, Foster City, Calif.). All the computer analyses of nucleotide sequences were carried out using programs in The Wisconsin Package (version 9.0; Genetics Computer Group [GCG], Madison, Wis.). A homology search was performed using BLAST and TFastA programs accessed via the EMBL (release no. 55.0) and GenBank (release no. 107.0) databases and the FastA program accessed via the SWISS-PROT database. (release no. 35.0).
PFGE. Pulsed-field gel electrophoresis (PFGE) was performed with a modification as described previously (32). For preparation of sample plugs, ca. 2 × 106 cells were embedded in 37.5 µl (1.5 by 5 by 5 mm) of 1% (wt/vol) low-temperature-melting agarose (Agarose Low Melt Preparative Grade; Bio-Rad Laboratories, Hercules, Calif.) containing 40 µg of lysostaphin (Sigma Chemical Co.) per ml. The sample plugs were incubated with 1% (wt/vol) N-lauroylsarcosine (Sigma Chemical Co.)-0.5 M EDTA, pH 7.5, at 37°C for 1 h and further incubated with a solution containing 2 mg of proteinase K (Sigma Chemical Co.) per ml, 1% (wt/vol) N-lauroylsarcosine (Sigma Chemical Co.), and 0.5 M EDTA, pH 7.5, at 50°C for 24 h. The plugs were then incubated with 1 mM phenylmethylsulfonyl fluoride (Sigma Chemical Co.) at 50°C for 30 min, followed by washing three times with Tris-EDTA (20 min each at 4°C). The samples were then treated with 60 U of SmaI (Takara Shuzo Co. Ltd., Kyoto, Japan) at 30°C for 24 h and next were treated with 200 µg of proteinase K at 37°C for 1 h. The final concentrations of SmaI and proteinase K were 0.4 U/µl and 100 µg/ml, respectively. They were further washed three times with Tris-EDTA at 4°C for 20 min and subjected to PFGE with 1.2% agarose gel (high-strength analysis-grade agarose; Bio-Rad Laboratories). The PFGE was performed at 4°C for 20 h in 0.5× Tris-borate-EDTA running buffer using a CHEF DRII apparatus (Bio-Rad Laboratories) with an electric field strength of ~6 V/cm and a pulse time of 20 s.
Electroporation.
Exponentially growing cultures of strain
N315 or N315ex were harvested at an optical density at 600 nm of 0.5 and washed with prechilled 1.1 M sucrose three times. The pellet was
resuspended in 100 µl of EP buffer (1.1 M sucrose, 2 mM
MgCl2, 14 mM
KH2PO4-Na2HPO4 [pH
7.4]). To the cell suspension, 5 µg of the plasmid DNA was added,
and the mixture was kept on ice for 25 min. An electric pulse of 25 µF, 2.5 kV, and 100
was delivered by a Gene Pulser (Nippon
Bio-Rad Laboratories, Tokyo, Japan). The cells were then transferred
into 0.5 ml of 1.1 M sucrose in BHI broth and incubated for 2 h at
30°C (permissive temperature for plasmid replication) before aliquots
were plated on BHI agar plates containing tetracycline (10 µg/ml).
After a 48-h incubation at 30°C, mature colonies were picked and
subjected to rapid plasmid analysis by digestion with various
restriction enzymes to confirm the integrity of the introduced plasmid.
The plasmid preparation procedure has been described previously
(32). The transformants were further colony purified by
streaking them onto the BHI agar plate with tetracycline (10 µg/ml)
and incubating the plate overnight before establishing the transformant
strains as those used in this study.
Southern blot hybridization. Southern transfer of DNA from the PFGE gel to a nylon membrane was performed as described previously (32). Hybridization took place in a hybridization solution (50% formamide, 5× SSC [1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 0.3% sodium dodecyl sulfate [SDS], 2% blocking reagent [Boehringer, Mannheim, Germany]) containing 20 ng of digoxigenin-labeled DNA probe per ml. Incubation was carried out for 16 h at 42°C. The orfX probe was prepared by using primers 5'-CCACGCATAATCTTAAATGCTCT-3' and 5'-AAACGACATGAAAATCACCAT-3' (primer cR2 [14]), which corresponded to the nucleotides from base positions 56,357 to 56,379 and complementary nucleotides from base positions 56,824 to 56,804 of the reported nucleotide sequence of orfX (accession no. D86934), respectively. The probe for the ermA gene was prepared using synthetic oligonucleotides 5'-TGAAACAATTTGTAACTATTGA-3' and 5'-TGAACCAGAAAAACCCTAAAGA-3' as primers, which corresponded to the nucleotides from positions 33,804 to 33,825 and the complementary nucleotides from position 34,530 to 34,509, respectively, of the reported nucleotide sequence of the N315 SCCmec (accession no. D86934 [14]). The cloned DNA fragment SJ2, which contains Tn554 of SCCmec, was used as the template for the PCR amplification of the ermA gene (14). These probes were labeled with digoxigenin using a DNA labeling kit (Boehringer). The hybridized filter (Biodyne A; Pall Biosupport Co., Glen Cove, N.Y.) was washed twice in 2× SSC with 0.1% SDS for 5 min at room temperature and then in 1× SSC with 0.1% SDS for 15 min at 68°C. Visualization of the signal was achieved using an alkaline phosphatase-conjugated antidigoxigenin antibody (Boehringer) and the chemiluminescent substrate CSPD (Boehringer) according to the procedure recommended by the manufacturers.
Synthetic oligonucleotides used as primers for PCR and nucleotide
sequencing.
The primers used in this study and their nucleotide
sequences with references, if not specified above, are listed below in the order of appearance in the text: cL1,
5'-ATTTAATGTCCACCATTTAACA-3' (14); mL1,
5'-GAATCTTCAGCATGTGATTTA-3' (corresponds to the
complementary nucleotides from positions 4,977 to 4,957 of the
nucleotide sequence [accession no. D86934]); mR8,
5'-ATGAAAGACTGCGGAGGCTAACT-3' (corresponds to the
nucleotides from base position 56,636 to 56,658 [accession no.
D86934]); cR2, 5'-AAACGACATGAAAATCACCAT-3' (14); mA1, 5'-TGCTATCCACCCTCAAACAGG-3' (10); mA2,
5'-AACGTTGTAACCACCCCAAGA-3' (10); mR7,
5'-AAAAAGTCGACACTGCTTGGGTAACTTATCATGGA-3'; mL2,
5'-AAAAAGTCGACATCACAGTAGTGCAAAGCACGTCGA-3';
,
5'-TTTCACACAGGAAACAGCTATGAC-3'; and
,
5'-ATCACGATATTGCTTATAAGCA-3' (corresponds to the nucleotides
from base positions 26,673 to 26,694 of the reported sequence
[accession no. D86934]).
| |
RESULTS |
|---|
|
|
|---|
ccrA and ccrB gene-mediated excision of
SCCmec.
Two novel ORFs, ccrA and
ccrB, were located in the midst of
SCCmec (Fig.
1A). CcrA and CcrB
polypeptides of 449 and 542 amino acids were potentially encoded by the
ORFs. A Shine-Dalgarno sequence and
10 and
35 presumptive promoter
sequences were identified immediately upstream of ccrA. On
the other hand, although Shine-Dalgarno sequence was found for
ccrB, no candidates for promoter sequences were identified
in the adjacent upstream region of the gene. This suggests that the two
ORFs may be transcribed as a single mRNA.
|
|
Concomitant appearance of a rearranged attachment sequence, attSCC, with SCCmec excision. Upon the precise excision, the excised SCCmec was expected to form an extrachromosomal closed circular DNA. To test this possibility, PCR was performed using a pair of primers set divergently at both termini of SCCmec (primers mR8 and mL1 [Fig. 1A]). Figure 2A shows that a DNA fragment of 0.5 kb was specifically amplified from N315(pSR) but not from the other test strains. Nucleotide sequencing of the fragment showed a novel nucleotide sequence presumably generated by a head-to-tail ligation of attSCC-R and attSCC-L of both termini of SCCmec, forming a novel attachment sequence designated attSCC (Fig. 2B). The divergently arranged 27-bp inverted repeats, IR-L and IR-R, with a core of four nucleotides, TTCT (underlined in Fig. 2B), between them and the presence of direct repeats, DR-SCC, were characteristic of the structure of the attSCC. The data suggested that a closed circular form of SCCmec was produced as a result of the precise excision of SCCmec from the N315 chromosome.
Loss of SCCmec during passage of
N315(pSR).
To see the rate of loss of
SCCmec from the culture of N315(pSR) and
confirm the precision of excision mediated by ccr genes, PFGE analysis on the total DNAs that were consecutively extracted from
the culture was performed (Fig. 3A).
Compared to the culture of N315 and N315(pYT3) (lanes 1 and 9, respectively), N315(pSR) had an extra band of about 160-kb (Fig.
3A, lane 2). The band was indistinguishable from that of N315ex, from
which a 215-kb band of N315 was missing (lane 8). As long as the
N315(pSR) was cultured in tobramycin-containing BHI broth, the
proportions of the two bands were the same: densitometric measurement
of the 215-, and 160-kb bands yielded a ratio of about 7 to 8:1 (data not shown). When, the cells were washed and resuspended in BHI broth
without tobramycin, the intensity of the 215-kb band of N315(pSR)
started decreasing and continued to do so during the course of the
passage, while the 160-kb band continued increasing in intensity (Fig.
3A, lanes 2 to 7). Southern blot hybridization of the PFGE bands using
orfX DNA as a probe showed that both the 215- and 160-kb
bands carried orfX (Fig. 3B). Rehybridization of the
membrane using the mecA gene probe showed that the 215-kb band hybridized with the probe, but the 160-kb band did not (data not
shown). This clearly showed that the loss of mecA gene was caused by the precise excision of SCCmec. Greater
than 99% of the cells in culture became susceptible to tobramycin and
methicillin after 10 days' passage of N315(pSR) without
tobramycin.
|
Site-specific, orientation-specific integration of experimental
plasmid mediated by ccr genes.
To investigate whether
the putative closed circular form of SCCmec serves
as a substrate for integration when introduced into a MSSA cell, we
constructed experimental plasmids pSRatt and pSRtta on which both
ccr genes and the presumptive attachment sequence, attSCC, are subcloned (14).
The plasmid pSRtta was identical with pSRatt except that the
attSCC fragment was cloned in the opposite
orientation (Fig. 4). The resultant
recombinant plasmids were introduced into strain N315ex by
electroporation, and transformants were selected by overnight
incubation on BHI agar plates containing tetracycline (10 µg/ml) at
30°C. The colony of each transformant was respread onto BHI agar
plates containing tetracycline (10 µg/ml) and incubated overnight at
30 or 43°C (nonpermissive temperature for the plasmid replication)
before enumeration of the generated colonies. Two strains,
N315ex(pSRatt) and N315ex(pSRtta), generated significant number of
colonies at 43°C, i.e., 17.7 and 21.2%, respectively, of those grown
at 30°C, whereas the other strains generated only small number of
colonies; i.e., <0.001% of those grown at 30°C. The result showed
that the chromosomal integration of the plasmids occurred only when
attSCC and an intact set of ccrA and
ccrB genes were present on the plasmids.
|
(RV in
pUC119) and
(in the ccrB gene) flanking the
attSCC region on the plasmids (Fig. 4). The
results showed that the plasmid pSRatt generated
plasmid-chromosome junctions which were detectable only by the
two combinations of the primers, L-
and R-
. On the other hand,
the plasmid-chromosome junctions generated by pSRtta were detected only
by the combinations of the primers, L-
and R-
. Integration in the
opposite orientation could not be detected with the sensitivity of PCR
employed in this study: the PCR sensitivity was such that it was
able to detect the integrated template in N315ex(pSRatt) DNA
diluted up to 104 times (wt/wt) with N315ex(pYT3att)
DNA (data not shown).
The amplified DNAs from N315ex(pSRatt) and from
N315ex(pSRtta) contained sequences which were identical with
those of the chromosome-SCCmec junction regions
(attL and attR) of N315 as presented in Fig. 1A.
PCR with any combinations of the primers did not amplify DNA fragments
on template DNAs extracted from any of the transformants [N315ex(pYT3), N315ex(pSRA*att), N315ex(pSRB*att), or
N315ex(pSR) (not shown)]. This showed that all of ccrA,
ccrB, and attSCC were required for the
integration of the experimental plasmids.
| |
DISCUSSION |
|---|
|
|
|---|
The size of SCCmec (52 kb) is comparable to those of other genetic elements such as bacteriophages, conjugative transposons, and pathogenicity islands, but SCCmec does not have any structural similarity to those previously identified genetic elements: it is distinguishable from conjugative transposons since it lacks the tra gene complex (5), and from bacteriophages because it lacks the structure genes (or their remnants) for head or tail proteins of bacteriophages (29). Unlike SCCmec pathogenicity islands (18, 19), does not contain any ORFs predictably encoding virulence factors as far as we could judge from the homology search of extant gene products (14). Besides these structural characteristics of SCCmec, we demonstrated, in this study, that SCCmec carries a set of unique recombinase genes, ccrA and ccrB, that are specifically involved in the recombination events (integration and excision) of SCCmec with the S. aureus chromosome. The presence of the two genes was required for both excision and integration processes of SCCmec. In other genetic elements, such as bacteriophage lambda and conjugative transposons, two site-specific recombinases, designated integrase and excisionase, are reported to be required for the excision process. However, in these elements, the integration can be mediated by the integrase alone (5, 29).
The Ccr recombinases are also characteristic in that their NH2-terminal thirds had a substantial homology to the recombinases of the invertase/resolvase family, whereas the integrases of bacteriophage lambda and conjugative transposons belong to the integrase family of site-specific recombinases. The characteristic serine residue that is considered to offer the hydroxyl group that attacks the DNA molecule in the strand exchange reaction is conserved among the recombinases of the invertase/resolvase family and in Ccr proteins as well, but Ccr proteins also differ considerably from the recombinases of the invertase/resolvase family in that they possess much larger COOH-terminal domains than those possessed by the recombinases belonging to this family. A homology search of the COOH-terminal domains did not find any homologue in the extant proteins. Therefore, the molecular evolutionary relationship of Ccr proteins to other recombinases and their mode of action pose intriguing questions to be explored.
Since the 1960s, the spontaneous loss of the mecA gene has been observed during the storage or long-term cultivation of MRSA strains in antibiotic-free medium (11). Deletion of a large chromosomal region is identified in such mecA deletion strains. The deletion starts precisely from the left boundary of IS431mec and extends leftwards for various distances beyond the mecA gene. The precise excision of SCCmec demonstrated in this study is unrelated to the transposase-mediated mecA deletions (14). Curiously, spontaneous precise excision does not occur appreciably during cultivation of N315 despite the fact that the strain carries an intact pair of ccr genes on its chromosome. The excision does, however, seem to occur at an extremely low frequency and can be detected by nested-PCR amplification of the attB sequence (14). Therefore, it is an intriguing question whether the expression of the intact copy of ccr genes of SCCmec is down regulated to stabilize the SCCmec in the chromosome. Alternatively, even an unrestricted expression of a single copy of the ccr genes on the chromosome may not be enough to increase the concentration of Ccr proteins to a level high enough to trigger the excision of SCCmec. A study is under way to clarify these points.
It is well known that the mecA gene is carried by many staphylococcal species besides S. aureus (13, 28), so it has been suspected that mecA is transmissible among staphylococcal species. In fact, methicillin resistance can be experimentally transferred between S. aureus cells by phage transduction (6). The DNA element with similar structural features to SCCmec is also identified in the strains of various staphylococcal species with the methicillin resistance phenotype (T. Ito, unpublished observation). Thus, it seems that the methicillin resistance gene mecA is transferred from cell to cell as a part of the SCCmec across staphylococcal species. However, as far as we are aware, no transducing phage capable of transferring genetic information across the staphylococcal species barrier has been described. Thus, it remains to be seen if SCCmec is transmissible by phage transduction or if some other genetic transfer system specific for the movement of SCCmec exists.
In conclusion, we have demonstrated that the methicillin resistance gene of MRSA is carried by a novel genetic element, SCCmec, whose integration into and excision from the S. aureus chromosome are mediated by a unique set of recombinase genes, ccrA and ccrB. Further study of the distribution of SCCmec and its related elements among S. aureus and other staphylococcal species will be helpful to elucidate how staphylococcal species exchange useful genetic information. Also, future elucidation of the mechanism of regulation of SCCmec excision may lead to the attractive possibility of the development of a novel therapeutic measure to aid in antibiotic chemotherapy against MRSA infection by converting MRSA strains in vivo into MSSA strains against which many extant antibiotics are effective.
| |
ACKNOWLEDGMENTS |
|---|
We thank K. Tsutsumimoto for her excellent technical assistance and Yasmin Abu Hanifah for valuable suggestions concerning the worldwide epidemiology of MRSA.
This work was supported by the Core University Program under the auspices of the Japan Society for the Promotion of Science (JSPS), coordinated by the Graduate School of Medicine, University of Tokyo, and School of Medical Sciences, Universiti Sains Malaysia, and by the Specially Designated Research Promotion of Monbusho, Japan.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Bacteriology, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8421. Phone: 81-3-5802-1040. Fax: 81-3-5684-7830. E-mail: hiram{at}med.juntendo.ac.jp.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ayliffe, G. A. 1997. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 24(Suppl. 1):74-79. |
| 2. | Barberis-Maino, L., B. Berger-Bachi, H. Weber, W. D. Beck, and F. H. Kayser. 1987. IS431, a staphylococcal insertion sequence-like element related to IS26 from Proteus vulgaris. Gene 59:107-113[CrossRef][Medline]. |
| 3. | Chambers, H. F., and H. C. Neu. 1995. Penicillins, p. 233-246. In G. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y. |
| 4. |
Christiansen, B.,
L. Brondsted,
F. K. Vogensen, and K. Hammer.
1996.
A resolvase-like protein is required for the site-specific integration of the temperate lactococcal bacteriophage TP901-1.
J. Bacteriol.
178:5164-5173 |
| 5. | Clewell, D. B. 1998. Conjugative transposons, p. 130-139. In F. J. de Bruijn, J. R. Lupski, and G. M. Weinstock (ed.), Bacterial genomes. Chapman and Hall, New York, N.Y. |
| 6. |
Cohen, S., and H. M. Sweeney.
1970.
Transduction of methicillin resistance in Staphylococcus aureus dependent on an unusual specificity of the recipient strain.
J. Bacteriol.
104:1158-1167 |
| 7. |
Dubin, D. T.,
P. R. Matthews,
S. G. Chikramane, and P. R. Stewart.
1991.
Physical mapping of the mec region of an American methicillin-resistant Staphylococcus aureus strain.
Antimicrob. Agents Chemother.
35:1661-1665 |
| 8. |
Hanaki, H.,
K. Kuwahara-Arai,
S. Boyle-Vavra,
R. S. Daum,
H. Labischinski, and K. Hiramatsu.
1998.
Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
J. Antimicrob. Chemother.
42:199-209 |
| 9. |
Hartman, B. J., and A. Tomasz.
1984.
Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus.
J. Bacteriol.
158:513-516 |
| 10. | Hiramatsu, K., K. Asada, E. Suzuki, K. Okonogi, and T. Yokota. 1992. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett. 298:133-136[CrossRef][Medline]. |
| 11. |
Hiramatsu, K.,
E. Suzuki,
H. Takayama,
Y. Katayama, and T. Yokota.
1990.
Role of penicillinase plasmids in the stability of the mecA gene in methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
34:600-604 |
| 12. | Hiramatsu, K., T. Ito, and H. Hanaki. 1999. Evolution of methicillin and glycopeptide resistance in Staphylococcus aureus, p. 221-242. In R. G. Finch, and R. J. Williams (ed.), Bailliere's clinical infectious disease. Bailliere Tindall, London, United Kingdom. |
| 13. |
Hurlimann-Dalei, R. L.,
C. Ryffel,
F. H. Kayser, and B. Berger-Bachi.
1992.
Survey of the methicillin resistance-associated genes mecA, mecR1-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
36:2617-2621 |
| 14. |
Ito, T.,
Y. Katayama, and K. Hiramatsu.
1999.
Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315.
Antimicrob. Agents Chemother.
43:1449-1458 |
| 15. | Jevons, M. P. 1961. "Celbenin"-resistant staphylococci. Br. Med. J. 1:124-125. |
| 16. |
Kreiswirth, B.,
J. Kornblum,
R. D. Arbeit,
W. Eisner,
J. N. Maslow,
A. McGeer,
D. E. Low, and P. R. Novick.
1993.
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus.
Science
259:227-230 |
| 17. | Kuwahara-Arai, K., N. Kondo-Hori, E. Tateda-Suzuki, and K. Hiramatsu. 1996. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP2' production. Antimicrob. Agents Chemother. 40:2680-2685[Abstract]. |
| 18. | Lee, C. A. 1996. Pathogenicity islands and the evolution of bacterial pathogens. Infect. Agents Dis. 5:1-7[Medline]. |
| 19. | Lindsay, J. A., A. Ruzin, H. F. Ross, N. Kurepina, and R. P. Novick. 1998. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol. Microbiol. 29:527-543[CrossRef][Medline]. |
| 20. |
Matsuhashi, M.,
M. D. Song,
F. Ishino,
M. Wachi,
M. Doi,
M. Inoue,
K. Ubukata,
N. Yamashita, and M. Konno.
1986.
Molecular cloning of the gene of a penicillin binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus.
J. Bacteriol.
167:975-980 |
| 21. |
Matthews, P., and A. Tomasz.
1990.
Insertional inactivation of the mec gene in a transposon mutant of a methicillin-resistant clinical isolate of Staphylococcus aureus.
Antimicrob. Agents Chemother.
34:1777-1779 |
| 22. | McKenzie, H. T., T. Hoshino, T. Tanaka, and N. Sueoka. 1986. The nucleotide sequence of pUB110: some salient features in relation to replication and its regulation. Plasmid 15:93-103[CrossRef][Medline]. |
| 23. | Murphy, E. L. Huwyler, and M. C. Bastos. 1985. Transposon Tn554: complete nucleotide sequence and isolation of transposition-defective and antibiotic-sensitive mutants. EMBO J. 4:3357-3365[Medline]. |
| 24. | Reynolds, P. E., and D. F. J. Brown. 1985. Penicillin-binding proteins of beta-lactam-resistant strains of Staphylococcus aureus. FEBS Lett. 192:28-32[CrossRef][Medline]. |
| 25. | Sherratt, D. 1989. Tn3 and related transposable elements: site-specific recombination and transposition, p. 163-184. In D. E. Berg, and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C. |
| 26. | Song, M. D., M. Wachi, M. Doi, F. Ishino, and M. Matsuhashi. 1987. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett. 221:167-171[CrossRef][Medline]. |
| 27. | Stewart, P. R., D. T. Dubin, S. G. Chikramane, B. Ingli, P. R. Matthews, and S. M. Poston. 1994. IS257 and small plasmid insertions in the mec region of the chromosome of Staphylococcus aureus. Plasmid 31:12-20[CrossRef][Medline]. |
| 28. |
Suzuki, E.,
K. Hiramatsu, and T. Yokota.
1992.
Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution.
Antimicrob. Agents Chemother.
36:429-434 |
| 29. | Thompson, J. F., and A. Landy. 1989. Regulation of bacteriophage lambda site-specific recombination, p. 1-22. In D. E. Berg, and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C. |
| 30. |
Utsui, Y., and T. Yokota.
1985.
Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
28:397-403 |
| 31. | Wada, A., Y. Katayama, K. Hiramatsu, and T. Yokota. 1991. Southern hybridization analysis of the mecA deletion from methicillin-resistant Staphylococcus aureus. Biochem. Biophys. Res. Commun. 176:1319-1325[CrossRef][Medline]. |
| 32. | Yoshida, T., N. Kondo, Y. A. Hanifah, and K. Hiramatsu. 1997. Combined use of ribotyping, PFGE typing and IS431 typing the discrimination of nosocomical strains of methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 41:687-695[Medline]. |
This article has been cited by other articles: